| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 6.942 | 11.662 | 558 | 0 | 1.221 | 334 |
| Total Income - EUR | - | - | - | - | 7.300 | 21.370 | 4.286 | 23.128 | 2.164 | 3.146 |
| Total Expenses - EUR | - | - | - | - | 8.344 | 26.642 | 14.747 | 25.741 | 970 | 3.298 |
| Gross Profit/Loss - EUR | - | - | - | - | -1.044 | -5.272 | -10.461 | -2.613 | 1.194 | -151 |
| Net Profit/Loss - EUR | - | - | - | - | -1.053 | -5.370 | -10.461 | -3.222 | 1.003 | -151 |
| Employees | - | - | - | - | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Aventa Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 19.639 | 44.350 | 35.745 | 14.459 | 13.473 | 10.584 |
| Current Assets | - | - | - | - | 13.732 | 852 | 22 | 6 | 818 | 94 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 9.999 | 592 | 0 | 0 | 244 | 0 |
| Cash | - | - | - | - | 3.734 | 261 | 22 | 6 | 574 | 94 |
| Shareholders Funds | - | - | - | - | -948 | -6.300 | -16.621 | -19.895 | -18.831 | -18.877 |
| Social Capital | - | - | - | - | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | - | - | - | - | 3.138 | 30.640 | 35.713 | 20.471 | 20.218 | 19.537 |
| Income in Advance | - | - | - | - | 31.181 | 20.862 | 16.674 | 13.889 | 12.904 | 10.019 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Aventa Medical S.r.l.